AlphaFold predicted structure
SCARB2 · Q14108

Mean pLDDT
92.8/ 100
Very high
478 residues
Confidence breakdown
- Very high(≥ 90)82%
- Confident(70–90)13%
- Low(50–70)3%
- Very low(< 50)2%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
scavenger receptor class B member 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Early onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy or pain disorder
BIALLELIC, autosomal or pseudoautosomalProteinuric renal disease
BIALLELIC, autosomal or pseudoautosomalUnexplained kidney failure in young people
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalMonogenic hearing loss
action myoclonus-renal failure syndrome
Action myoclonus - renal failure syndrome
Progressive myoclonic epilepsy
hereditary disease
Rolandic epilepsy
self-limited epilepsy with centrotemporal spikes
Unverricht-Lundborg disease
Unverricht-Lundborg syndrome
progressive myoclonus epilepsy
Gaucher disease type 1
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Lysosome membrane protein 2
Acts as a lysosomal receptor for glucosylceramidase (GBA1) targeting
SCARB2 · Q14108

Mean pLDDT
92.8/ 100
Very high
478 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0